Money from Sick People Part IV: Paying a Premium for Drug Pricing Irregularity — 46brooklyn Research Starting with the Q1 2023 Drug Pricing file (all of this information was knowable before the 2024 Medicare plan bid process was completed). Within the files are the five insulin products we identified as taking large price decreases. 46 Brooklyn identifies each of the specific drug products (i.e. dosage form and strength) at the NDC-level, the...
Read More »